U.S. IVF cycle volumes jumped 33% from 2020 to 2022, but gains slowed dramatically after initial COVID-era spike
BY INSIDE REPRODUCTIVE HEALTH
Cycle Volumes Rose 33% in Two Years—But Most of It Happened in One
IVF cycle volume data analyzed in Inside Reproductive Health’s latest industry report, reveals a 33% increase in total U.S. IVF cycle volume between 2020 and 2022. But the majority of that growth occurred between 2020 and 2021, highlighting a marked slowdown in the subsequent year.
The analysis, which covers every reporting IVF lab in the country, shows that cycle volume rose 26.7% from 2020 to 2021, representing 87,308 more cycles than the previous year. However, growth dropped to just 5.2% from 2021 to 2022, a gain of 21,650 cycles.
The report uses CDC ART data to track total IVF cycles per lab over the three-year period and quantifies both annual and total percentage changes. The dataset offers executives a comparative lens to assess performance and market trends across regions, especially during a time of shifting patient demand and ongoing consolidation in the fertility space.
IVF Volume Leaders: Every U.S. Lab, Their Cycle Counts, and 2-Year Growth or Decline
List reveals the biggest IVF volume shifts from 2020 to 2022.
Between 2020 and 2022, total IVF cycle volume in the U.S. increased by just over 33%, with significant variability across regions and clinic types. While some labs saw sustained double-digit growth year-over-year, others experienced contractions or stagnation.
In this free report, you’ll get:
📊 IVF cycle volumes for every reporting lab from 2020–2022
📈 Growth trends across 600+ clinics
🔍 Top 5 fastest-growing IVF centers (and which ones are slowing down)
🧭 Year-over-year performance data to benchmark your own lab
Download now to find out where your lab stands—and what the market’s telling you.
Northeast Corridor Dominates Growth Rankings
Among the most notable trends: all five of the highest-growth IVF centers from 2020 to 2022 were located in the Northeast Corridor. However, only one of those—RMA-New Jersey—posted continued growth from 2021 to 2022. The remaining four centers saw slight declines during that final year despite their high cumulative gains over the full three-year period.
The uneven distribution of growth underscores the importance of geographic strategy in a post-COVID fertility market. While patient demand surged in the early phase of the pandemic, the data suggests that momentum was harder to sustain across the board.
Nearly 40% of Labs Did Not Grow In 2022
The year-over-year data also reveals a decrease in the number of labs reporting growth. Between 2020 and 2021, 78% of IVF labs increased their cycle volumes. That percentage dropped to 61% from 2021 to 2022, indicating a broader market deceleration.
These figures raise important questions for executives monitoring expansion plans, lab capacity, and strategic partnerships. With growth slowing industry-wide, competition may intensify for patient volume, particularly in saturated or previously high-performing regions.
Report Provides Cycle Counts for Every Lab
The report includes total IVF cycles per lab for each year from 2020 through 2022, along with the percentage change between years and overall three-year volume shifts. Clinics were included only if they consistently reported data across the period and were not newly opened partway through a year.
The data was drawn from three CDC datasets and refined to include only rows showing “Total Cycles,” in line with CDC definitions of ART cycles. Labs that changed names were consolidated under their most recent name, and non-reporting or closed clinics were excluded.
Importantly, the report does not segment cycle types or explore outcomes—its sole focus is year-over-year cycle activity. Fertility preservation cycles, clinical outcomes, or patient demographics were not part of the scope.
Growth May Be Leveling Off for Now
While the data confirms a post-COVID boom in IVF cycles, it also signals a leveling-off effect that could shape strategic decisions across the industry. With growth tapering and regional disparities widening, lab operators, investors, and executives may need to recalibrate expectations for expansion in 2025 and beyond.
The full dataset is available in Inside Reproductive Health’s industry report, sponsored by Vitrolife
IVF Volume Leaders: Every U.S. Lab, Their Cycle Counts, and 2-Year Growth or Decline
List reveals the biggest IVF volume shifts from 2020 to 2022.
Between 2020 and 2022, total IVF cycle volume in the U.S. increased by just over 33%, with significant variability across regions and clinic types. While some labs saw sustained double-digit growth year-over-year, others experienced contractions or stagnation.
In this free report, you’ll get:
📊 IVF cycle volumes for every reporting lab from 2020–2022
📈 Growth trends across 600+ clinics
🔍 Top 5 fastest-growing IVF centers (and which ones are slowing down)
🧭 Year-over-year performance data to benchmark your own lab
Download now to find out where your lab stands—and what the market’s telling you.
This News Digest Story is paid featured content. The advertiser has had editorial input and control over its creation. However, the views and opinions expressed in this article do not necessarily represent the views of Inside Reproductive Health. The sponsorship of this content does not imply an endorsement by Inside Reproductive Health.
